Citadel Advisors
DERM icon

Citadel Advisors’s Journey Medical DERM Stock Holding History

Citadel Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Buy
+82,149
New +$469K ﹤0.01% 9497
2026
Q1 		– Sell
-69,415
Closed -$535K – 13196
2025
Q4 		$535K Buy
69,415
+55,025
+382% +$431K ﹤0.01% 8866
2025
Q3 		$102K Buy
+14,390
New +$104K ﹤0.01% 11840
2025
Q2 		– Sell
-49,259
Closed -$291K – 12990
2025
Q1 		$291K Buy
49,259
+4,691
+11% +$23.1K ﹤0.01% 9672
2024
Q4 		$174K Buy
+44,568
New +$244K ﹤0.01% 10665
2024
Q1 		– Sell
-11,357
Closed -$65.4K – 14691
2023
Q4 		$65.4K Buy
+11,357
New +$50.6K ﹤0.01% 11474
2022
Q1 		– Sell
-10,761
Closed -$58K – 13748
2021
Q4 		$58K Buy
+10,761
New +$77.9K ﹤0.01% 13165

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Citadel Advisors's DERM Position: Q2 2026 in Review

Citadel Advisors opened a new position in Journey Medical (DERM) in Q2 2026: 82,149 shares worth $582K. The stake represents ﹤0.01% of the portfolio and ranks #9497 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in DERM as recently as Q4 2025.

Citadel Advisors first reported a position in DERM in Q4 2021 and has held it in 7 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Citadel Advisors held 82,149 shares of Journey Medical worth $582K as of Q2 2026.
  • Journey Medical was a new Citadel Advisors position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9497 holding.
  • Citadel Advisors first reported a position in Journey Medical in Q4 2021 and has held it in 7 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.